Clovis Oncology, Evergreen partner for actinium-225-labeled FAP-2286

Clovis Oncology and Evergreen will develop radiolabelling chemistry and analytical methods for future pre-clinical and clinical studies. Credit: National Cancer Institute on Unsplash.